Navigation Links
New perspectives on health disparities in breast cancer research
Date:11/28/2007

frican-American women 31.6 percent of African-American women experienced relapse versus 14.9 percent of all other women.

If early breast cancer is more aggressive in African-American women, they may benefit from earlier detection than is previously obtained by yearly screening mammograms, Nichols said. These results should offer hope to the healthcare community, because improved, more vigilant, screening may offer a simple way to improve outcomes for African-American women with early breast cancer.


Physician perspectives on surgical treatment disparities among Asian women with early stage breast cancer, Abstract no. A-54:

According to the oncologists who treat them, Asian women with early stage breast cancer are influenced by cultural factors when they decide to choose mastectomy over breast-conserving lumpectomy, even though a lumpectomy might offer a better quality of life, say researchers at the Northern California Cancer Center (NCCC), located in Fremont, California.

An Asian patients attitude that the breast doesnt need to be preserved − primarily because of the cultures reduced emphasis on the breast and breast appearance − is an important consideration that leads many Asian women to choose a mastectomy, said a majority of physicians who participated in the investigators survey.

Other reasons cited by physicians are that Asian women may choose a mastectomy because breast size in this population is smaller to begin with, so there is less breast to preserve, as well as factors such as age and unwillingness to travel for chemotherapy and radiation treatments which often are necessary following a lumpectomy.

Reasons for why Asian women choose mastectomy are important, say the NCCC team, because in order for a breast cancer patient to make the best clinical decision, she must be thoroughly educated on the benefits of each procedure. For patients with early stage breast can
'/>"/>

Contact: Greg Lester
greg.lester@aacr.org
267-646-0554
American Association for Cancer Research
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Brookings: Donor Perspectives on Innovative Financing for Global Health
2. Penn study finds pro-death proteins required to regulate healthy immune function
3. UCLA researchers identify markers that may predict diabetes in still-healthy people
4. Air pollution linked to cardiovascular risk indices in healthy young adults
5. More proof needed of safety and quality of electronic personal health records
6. Health care incentive model offers collaborative approach
7. Loneliness is bad for your health
8. Mailman School of Public Health study examines link between racial discrimination and substance use
9. Green Tea May Brew Up Healthier Skin
10. For Health Info, Women Often Turn to the Web
11. Record Number of Americans Lack Health Insurance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2009)... recognized as a leader in the Collection Industry for the ... traditional collection agencies in speed, cost, and customer retention. ... ... A.R.M. Solutions, a leading provider of flat-fee collection services, was ... Collections by insideARM.com. This is the second time this year ...
(Date:12/7/2009)... to reverse some of the damage to their lungs ... cigarettes, according to research out of the University of ... published in the December 15 issue of the American ... Care Medicine . , "We found that exposure to ... epithelium, or lining, of the airways in the lung. ...
(Date:12/6/2009)... the loss of a key segment of DNA can lead ... show that this kind of genetic alteration can cause obesity. ... The study, led by Dr Sadaf Farooqi from the University ... Sanger Institute, looked at 300 children with severe obesity. , ... of mutation known as copy number variants (CNVs). CNVs are ...
(Date:12/6/2009)... Dec. 6 Sickle cell disease, a ... cells, is one of the most common genetic ... world, including more than 70,000 Americans.(1) Research presented ... American Society of Hematology highlights intriguing studies on ... for children with this blood disorder, evaluations of ...
(Date:12/6/2009)... Attorney Joseph W. Belluck of Belluck & Fox, LLP says dangerous ... holiday seasons. , ... New York, NY (PRWEB) December ... holiday season, they should be alert to reports of recalls due ... injury lawyer., , ,“Close to 230,000 children visit hospital emergency rooms ...
Breaking Medicine News(10 mins):Health News:Collection Agency Named One of 2009 Best Places to Work 2Health News:Quitting smoking can reverse asthma-inducing changes in lungs 2Health News:Genetic studies reveal new causes of severe obesity in childhood 2Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 2Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 3Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 4Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 5Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 6Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 7Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 8Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 9Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 3
... commercial companies over clinical and preclinical trial data—could jeopardize ... harm public health, says Karin Timmermans of the World ... ,Writing in a personal capacity, Ms Timmermans ... generic versions of the "flu drug" oseltamivir in the ...
... Delhi: Only three private hospitals out of the 26 land ... provide free treatment to poor patients,// according to a report ... ,The Delhi Development Authority and the Land & Development ... to various trusts and societies to establish hospitals out of ...
... allow a pioneering doctor, currently under house arrest in Henan ... award for her work on behalf// of HIV/AIDS patients, it ... had permission to travel," retired professor Gao Yaojie, 79, told ... holding her under house arrest for two weeks. ...
... thanking doctors who clutched at the last straw to save their ... Longfellow was born last August when his mother was just into ... weight was bad enough, but this was worsened when his lungs ... duct in the heart had not closed properly. He was operated ...
... promise in slowing progression and prolonging survival time in ... of targeted anti-cancer drugs that blocks the human epidermal ... the lives of patients with recurrent prostate cancer, a ... compound called pertuzumab, works by binding to and inhibiting ...
... mathematical model of disease cycles developed at the University ... ,Speaking in a symposium titled "New Vistas in ... meeting of the American Association for the Advancement of ... discuss how models that she and coworkers have developed ...
Other Medicine News:Health News:Drug Companies Should Not Have a Monopoly Over Clinical Trial Data 2Health News:Private Hospitals Ignore Deal to Provide Free Treatment 2Health News:Viagra Plays Another Role-Premature Baby Saved 2Health News:New Drug Promises Prolonged Survival in Prostate Cancer Patients 2Health News:New Drug Promises Prolonged Survival in Prostate Cancer Patients 3Health News:Mathematical Model Predicts Cholera Outbreaks 2
(Date:12/4/2009)... N.J., Dec. 4 Watson Pharmaceuticals, Inc. (NYSE: ... today confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, filed ... Food and Drug Administration seeking approval to market its ... patent owned by Takeda Pharmaceutical Company Limited. Watson,s ...
(Date:12/4/2009)... anxiety disorder, bipolar disorder, Attention Deficit Hyperactivity Disorder ... the comorbidities reported to occur more often in ... epilepsy versus those without an epilepsy diagnosis, according ... the U.S. ,, Findings from " CNS-Related Comorbidities ...
(Date:12/3/2009)... Pharmacyclics, Inc. (Nasdaq: PCYC ), a biopharmaceutical company ... for the treatment of immune mediated diseases and cancer, ... conference call on, Tuesday, December 8, 2009 at 11:00am ... to discuss clinical data regarding its HDAC Program (PCI-24781) ...
Breaking Medicine Technology:Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 6418 1The Deal Names Abbott Top Dealmaker for Second Consecutive Year 6418 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 6418 3AUDIO from Medialink and Ortho McNeil Janssen Pharmaceuticals Inc 3A Getting Ready for Cold and Flu Season 6416 1Preventing H1N1 spread to health care workers 3A Dilemma debate and confusion 61746 1Preventing H1N1 spread to health care workers 3A Dilemma debate and confusion 61746 2
... Participating in Bavituximab U.S. Cancer Trial Presents ... to Anti-Angiogenesis Experts -, TUSTIN, Calif., ... PPHM ), a clinical stage biopharmaceutical,company developing ... and,hepatitis C virus infection (HCV), today reported ...
... New data showed that at 48,weeks, significantly ... to non-nucleoside reverse transcriptase inhibitors,(NNRTIs) and protease ... as less than 50 HIV-1 RNA copies/mL) ... (BR) compared with placebo plus a BR.,These ...
Other Medicine Technology:Clinical Experience With Peregrine's Anti-Cancer Agent Bavituximab Presented at Leading Symposium on Anti-Angiogenic Agents 2Clinical Experience With Peregrine's Anti-Cancer Agent Bavituximab Presented at Leading Symposium on Anti-Angiogenic Agents 3Clinical Experience With Peregrine's Anti-Cancer Agent Bavituximab Presented at Leading Symposium on Anti-Angiogenic Agents 4New 48-Week Efficacy and Safety Data Presented for INTELENCE(TM) (etravirine) as Part of HIV Combination Therapy 2New 48-Week Efficacy and Safety Data Presented for INTELENCE(TM) (etravirine) as Part of HIV Combination Therapy 3New 48-Week Efficacy and Safety Data Presented for INTELENCE(TM) (etravirine) as Part of HIV Combination Therapy 4New 48-Week Efficacy and Safety Data Presented for INTELENCE(TM) (etravirine) as Part of HIV Combination Therapy 5New 48-Week Efficacy and Safety Data Presented for INTELENCE(TM) (etravirine) as Part of HIV Combination Therapy 6
... density. Proven ergonomic design reduces hand fatigue, prevents injury. Dry seal technology. ... 10-100 Inaccuracy ... 1.2~2.5 Imprecision(%) ... 1 Dimensions: ...
Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....
... Seven digital models cover the range from 2ul ... fluently. Volume lock design prevents inadvertent volume ... horizontal grip. Whole pipette is autoclavable at ... is all polypropylene. Suitable for one-handed operation. ...
Research Series 2100 Adjustable-volume Pipette, 10-100 l, single-channel with adjustable-volume setting...
Medicine Products: